The FDA recently approved a request to manufacture a generic version of mifepristone, a drug used in medication abortions, which has drawn sharp criticism from anti-abortion advocates. This approval allows Evita Solutions to produce its version of the drug, despite ongoing efforts to restrict access to mifepristone since the overturning of Roe v Wade. Critics, including some politicians and anti-abortion groups, have expressed outrage and questioned the FDA’s decision, citing safety concerns and recent studies. However, abortion rights supporters and medical professionals maintain that mifepristone is safe and effective, pointing to numerous studies supporting its use.
Read More
Protecting the public from misinformation requires vigilance, especially when it comes to health and medicine. The organization is committed to delivering unbiased, factual reporting to combat the spread of dangerous medical myths. Readers’ past support was crucial to the organization’s success and has allowed them to remain strong. Now, they are calling on readers to join and contribute once more to safeguard science and protect public health.
Read More
HuffPost, a news source dedicated to fact-based journalism, has been operating for two decades and remains committed to its mission. The publication is seeking support to continue its work. Reader contributions have been crucial in building and sustaining their newsroom, particularly during challenging periods. HuffPost hopes readers will continue to support its efforts.
Read More
Grace claimed that Capriglione’s stance on abortion was hypocritical, alleging he funded abortions despite presenting himself as anti-abortion. This is particularly notable as Capriglione authored Texas’s stringent “trigger” abortion ban, which makes performing an abortion a felony. Capriglione admitted to infidelity but denied paying for any abortions, stating his family has forgiven him.
Read More
A federal judge has ruled that Planned Parenthood clinics nationwide must continue to receive Medicaid funding, despite efforts by the Trump administration to defund the organization. The court order blocks the federal government from excluding groups like Planned Parenthood from Medicaid reimbursements, as the organization has a substantial likelihood of success in its legal challenge. This decision is a result of a lawsuit filed by Planned Parenthood, who argued that cutting off Medicaid funds would force nearly 200 clinics to close, impacting over a million patients. The lawsuit challenges a provision in Trump’s tax bill that targeted abortion providers receiving over $800,000 from Medicaid in 2023, even if they provide other medical services.
Read More
In a recent development, a New York county clerk has once again refused to file a Texas civil judgment against a doctor accused of prescribing abortion pills. This decision is based on New York’s shield law, which protects providers from legal actions in states with abortion bans. Despite demands from the Texas Attorney General’s office, the clerk has maintained the rejection, citing New York law. This case, along with another involving extradition to Louisiana, could test the boundaries of state shield laws and the legal battles surrounding abortion access.
Read More
Report: More Texans crossed state lines to get an abortion than anywhere in the U.S.
It’s pretty clear, isn’t it? The sheer size of Texas, combined with its restrictive abortion laws, makes it almost inevitable that a significant number of Texans would seek care elsewhere. This report isn’t just a headline; it’s a direct consequence of political choices. The fact that Texas leads in this grim statistic speaks volumes about the state’s policies and their impact on women’s access to healthcare. It is a reality, and the numbers bear it out.
Report: More Texans crossed state lines to get an abortion than anywhere in the U.S.… Continue reading
The Supreme Court has blocked Planned Parenthood from suing South Carolina over the state’s decision to defund the organization’s Medicaid funding due to abortion services provided. The 6-3 ruling, written by Justice Neil Gorsuch, focused on whether a specific law allowed for private lawsuits, ultimately finding that it did not. The decision, which split along conservative and liberal lines, sparked debate regarding the implications for Medicaid recipients’ access to care and the ability to enforce their rights. This ruling potentially opens the door for other states to defund Planned Parenthood and restricts Medicaid beneficiaries’ ability to choose their healthcare providers.
Read More
The Trump administration rescinded Biden-era guidance clarifying the Emergency Medical Treatment and Labor Act (EMTALA) in relation to abortion bans, claiming it will continue to enforce EMTALA while rectifying “perceived legal confusion.” This decision, opposed by abortion rights supporters who cite potential endangerment to pregnant patients, follows multiple state legal challenges to the Biden administration’s interpretation of EMTALA. The reversal comes after the Supreme Court declined to rule on a related Idaho case, leaving uncertainty regarding the scope of EMTALA in medical emergencies involving pregnancy. Critics argue this action prioritizes state abortion bans over patient safety.
Read More
Medication abortion, a two-step process using mifepristone and misoprostol, constitutes over half of all US abortions and is increasingly vital due to abortion restrictions. Highly effective before ten weeks of pregnancy, mifepristone’s access has become fiercely contested since the overturning of Roe v. Wade. Recent legal challenges to the drug’s availability were dismissed by the Supreme Court due to the plaintiffs lacking legal standing. This ruling, however, does not guarantee continued nationwide access to the drug.
Read More
John Q. Hosedrinker 
Matt Underwood